Given the complexity and redundancy of the VEGF signaling network in promoting angiogenesis and lymphangiogenesis, multitargeting by small molecules may be an appropriate strategy for effective inhibition of tumor-associated lymphangiogenesis. The gene discussed is VEGFA; the disease is neoplasm.